WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TNGX

Based on 8 analysts offering 12 month price targets for Tango Therapeutics Inc

Min Forecast
$12.00-42.64%
Avg Forecast
$18.75-10.37%
Max Forecast
$27.00+29.06%

Should I buy or sell TNGX stock?

Based on 8 analysts offering ratings for Tango Therapeutics Inc.

Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TNGX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TNGX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their TNGX stock forecasts and price targets.

TNGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-11
lockedlocked$00.00+00.00%2026-03-09Find Out Why
lockedlocked$00.00+00.00%2026-03-06
lockedlocked$00.00+00.00%2026-03-06Find Out Why
lockedlocked$00.00+00.00%2026-03-06
Piper Sandler
Top 8%
93
Strong BuyMaintains$14.00-33.08%2026-01-16Find out why
B. Riley Securities
Top 8%
93
Strong BuyMaintains$14.00-33.08%2025-11-18Find out why
Guggenheim
Top 20%
81
Strong BuyMaintains$12.00-42.64%2025-10-24Find out why

1 of 1

Forecast return on equity

Is TNGX forecast to generate an efficient return?

Company
-39.02%
Industry
69.63%
Market
179.33%
TNGX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TNGX forecast to generate an efficient return on assets?

Company
-33.88%
Industry
31.99%
TNGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TNGX earnings per share forecast

What is TNGX's earnings per share in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
-$1.28
Avg 2 year Forecast
-$1.43
Avg 3 year Forecast
-$1.19

TNGX revenue forecast

What is TNGX's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$36.3M-41.74%
TNGX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TNGX revenue growth forecast

How is TNGX forecast to perform vs Biotechnology companies and vs the US market?

Company
-21.91%
Industry
38.45%
Market
13.54%
TNGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TNGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TNGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TNGX$20.92$18.75-10.37%Strong Buy
TARS$70.15$96.60+37.70%Strong Buy
DYN$18.13$37.00+104.08%Strong Buy
CPRX$24.76$35.00+41.36%Strong Buy
IDYA$33.32$54.30+62.97%Strong Buy
View Top Biotech Stocks

Tango Therapeutics Stock Forecast FAQ

Is Tango Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: TNGX) stock is to Strong Buy TNGX stock.

Out of 8 analysts, 5 (62.5%) are recommending TNGX as a Strong Buy, 3 (37.5%) are recommending TNGX as a Buy, 0 (0%) are recommending TNGX as a Hold, 0 (0%) are recommending TNGX as a Sell, and 0 (0%) are recommending TNGX as a Strong Sell.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.

What is TNGX's earnings growth forecast for 2026-2028?

(NASDAQ: TNGX) Tango Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.24%.

Tango Therapeutics's earnings in 2026 is -$101,594,000.On average, 13 Wall Street analysts forecast TNGX's earnings for 2026 to be -$182,327,814, with the lowest TNGX earnings forecast at -$212,549,312, and the highest TNGX earnings forecast at -$167,802,089. On average, 9 Wall Street analysts forecast TNGX's earnings for 2027 to be -$203,759,679, with the lowest TNGX earnings forecast at -$253,101,484, and the highest TNGX earnings forecast at -$148,325,061.

In 2028, TNGX is forecast to generate -$170,284,875 in earnings, with the lowest earnings forecast at -$201,362,507 and the highest earnings forecast at -$88,395,743.

What is TNGX's revenue growth forecast for 2026-2028?

(NASDAQ: TNGX) Tango Therapeutics's forecast annual revenue growth rate of -21.91% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.

Tango Therapeutics's revenue in 2026 is $62,384,000.On average, 12 Wall Street analysts forecast TNGX's revenue for 2026 to be $0, with the lowest TNGX revenue forecast at $0, and the highest TNGX revenue forecast at $0. On average, 11 Wall Street analysts forecast TNGX's revenue for 2027 to be $0, with the lowest TNGX revenue forecast at $0, and the highest TNGX revenue forecast at $0.

In 2028, TNGX is forecast to generate $5,186,311,667 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $11,326,640,992.

What is TNGX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TNGX) forecast ROA is -33.88%, which is lower than the forecast US Biotechnology industry average of 31.99%.

What is TNGX's Price Target?

According to 8 Wall Street analysts that have issued a 1 year TNGX price target, the average TNGX price target is $18.75, with the highest TNGX stock price forecast at $27.00 and the lowest TNGX stock price forecast at $12.00.

On average, Wall Street analysts predict that Tango Therapeutics's share price could fall to $18.75 by Mar 11, 2027. The average Tango Therapeutics stock price prediction forecasts a potential downside of 10.37% from the current TNGX share price of $20.92.

What is TNGX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TNGX) Tango Therapeutics's current Earnings Per Share (EPS) is -$0.87. On average, analysts forecast that TNGX's EPS will be -$1.28 for 2026, with the lowest EPS forecast at -$1.49, and the highest EPS forecast at -$1.18. On average, analysts forecast that TNGX's EPS will be -$1.43 for 2027, with the lowest EPS forecast at -$1.77, and the highest EPS forecast at -$1.04. In 2028, TNGX's EPS is forecast to hit -$1.19 (min: -$1.41, max: -$0.62).

What is TNGX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TNGX) forecast ROE is -39.02%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.